tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Stock WebsitesTop Gainers/ Losers/ Active StocksDividend StocksChatGPT Stocks
ETFs
ETF CenterTop ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Crypto CenterBitcoin
Popular
Ethereum
Options
Options Market Overview Unusual Options Activity
Popular
Most Active OptionsOptions Volume Leaders
Research Tools
Stock ScreenerETF Screener
Popular
Compare StocksCompare ETFsTrending StocksTechnical Analysis ScreenerPenny Stock ScreenerDaily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Stock Websites
Top Gainers/ Losers/ Active Stocks
Dividend Stocks
ChatGPT Stocks
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Research Tools
Stock Screener
ETF Screener
Popular
Compare Stocks
Compare ETFs
Trending Stocks
Technical Analysis Screener
Penny Stock Screener
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Enterprise Solutions
Plans & Pricing
Education
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
Knight Therapeutics (KHTRF)
OTHER OTC:KHTRF
KHTRF
Knight Therapeutics
Stock Analysis
Analyst Forecasts
Technical Analysis
Chart
Earnings
Dividends
Ownership
Financials
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Knight Therapeutics (KHTRF) Stock News & Sentiment

31 Followers
Knight Therapeutics price target lowered to C$5.25 from C$5.40 at Stifel
The FlyKnight Therapeutics price target lowered to C$5.25 from C$5.40 at Stifel
22d ago
Knight Therapeutics price target raised to C$7 from C$6.75 at Canaccord
The FlyKnight Therapeutics price target raised to C$7 from C$6.75 at Canaccord
22d ago
Knight Therapeutics sees 2023 revenue C$325M-C$335M
The FlyKnight Therapeutics sees 2023 revenue C$325M-C$335M
23d ago
Knight Therapeutics reports Q3 EPS C$0.09 vs. C$0.01 last year
The FlyKnight Therapeutics reports Q3 EPS C$0.09 vs. C$0.01 last year
23d ago
Knight Therapeutics Reports Third Quarter 2023 Results
Press ReleasesKnight Therapeutics Reports Third Quarter 2023 Results
23d ago
Is KHTRF a Buy, Before Earnings?
Pre-EarningsIs KHTRF a Buy, Before Earnings?
25d ago
Knight Therapeutics announces CMED price approval of Minjuvi in Brazil
The FlyKnight Therapeutics announces CMED price approval of Minjuvi in Brazil
2M ago
More KHTRF News >

KHTRF News on the Web

Knight Therapeutics: Strong Q3 Results and Positive Outlook Drive Buy Rating
TipRanks News
Neutral
Notice of Knight Therapeutics' Third Quarter 2023 Results Conference Call
Yahoo Finance
Neutral
Knight Therapeutics investors are sitting on a loss of 44% if they invested five years ago
Yahoo Finance
Neutral
Knight Therapeutics Announces CMED Price Approval of Minjuvi® in Brazil
Yahoo Finance
Neutral
Knight Therapeutics Announces Regulatory Submission of Pemigatinib in Brazil
Yahoo Finance
Neutral
Knight Therapeutics Inc. places No. 90 on The Globe and Mail's fifth-annual ranking of Canada's Top Growing Companies
Yahoo Finance
Neutral
Executive Chairman of Knight Therapeutics Jonathan Goodman Buys More Stock
Yahoo Finance
Bullish
Individual investors account for 43% of Knight Therapeutics Inc.'s ownership, while private companies account for 22%
Yahoo Finance
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is KHTRF’s Media Buzz Sentiment?
Currently, no data Available
What is KHTRF’s weekly average amount of articles?
Currently, no data Available
What is KHTRF’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
SWTXSpringworks Therapeutics
PBYIPuma Biotechnology
PHGKoninklijke Philips
CICigna
IMGNImmunoGen
Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis
Subscribe NowSee Plans & Pricing